|
MAP1LC3B2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.53419993060334E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08099999999822E-05 |
| Normal-vs-Stage2 |
1.913820E-02 |
| Normal-vs-Stage3 |
4.97935026544383E-13 |
| Normal-vs-Stage4 |
1.8817000180249E-09 |
| Stage1-vs-Stage2 |
7.672600E-01 |
| Stage1-vs-Stage3 |
4.13420000000553E-06 |
| Stage1-vs-Stage4 |
5.600800E-03 |
| Stage2-vs-Stage3 |
4.098200E-03 |
| Stage2-vs-Stage4 |
2.277500E-02 |
| Stage3-vs-Stage4 |
4.193600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75469971885889E-10 |
| Normal-vs-AfricanAmerican |
2.183500E-02 |
| Normal-vs-Asian |
3.275800E-01 |
| Caucasian-vs-AfricanAmerican |
8.440500E-02 |
| Caucasian-vs-Asian |
7.240200E-01 |
| AfricanAmerican-vs-Asian |
7.839800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21189996821403E-09 |
| Normal-vs-Female |
2.82680000518454E-08 |
| Male-vs-Female |
9.548200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.191800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.71420000000455E-06 |
| Normal-vs-Age(61-80Yrs) |
2.69639865990712E-11 |
| Normal-vs-Age(81-100Yrs) |
6.280400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.030200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.491400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.872800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.229670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.116200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.032400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.225000E-01 |
| Normal-vs-Grade 2 |
4.20579999715898E-08 |
| Normal-vs-Grade 3 |
1.91290000506328E-08 |
| Normal-vs-Grade 4 |
1.42230005550914E-09 |
| Grade 1-vs-Grade 2 |
6.189900E-02 |
| Grade 1-vs-Grade 3 |
7.696500E-02 |
| Grade 1-vs-Grade 4 |
7.803900E-03 |
| Grade 2-vs-Grade 3 |
4.508400E-01 |
| Grade 2-vs-Grade 4 |
9.004400E-03 |
| Grade 3-vs-Grade 4 |
8.804400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.44719999983778E-07 |
| Normal-vs-ccB subtype |
3.53949999976066E-07 |
| ccA subtype-vs-ccB subtype |
5.361600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06109999570481E-08 |
| Normal-vs-N1 |
9.51809999999442E-05 |
| N0-vs-N1 |
3.378800E-01 |
|
|
